esophageal injury during Atrial Fibrillation Ablation
Conditions
Interventions
Experimental group:esophageal retractor
Sponsors
Beijing An-Zhen Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Subject is willing and able to provide informed consent; 2.Subject is between ages 18 – 80 years; 3.Subject has an atrial or ventricular arrhythmia requiring radiofrequency ablation on the posterior aspect of the heart; 4.Subject is capable of adhering to the expectations of the study protocol (e.g., attending follow-up visit).
Exclusion criteria
Exclusion criteria: 1.Patients with a history of severe cardiovascular and pulmonary diseases, including severe cardiac rhythm or abnormal conduction, Acute coronary syndrome, congestive heart failure; 2.Peoplehave pathological change in nasal cavity and throat; 3.There were contraindications to endoscopy; 4.Chest radiation or Nasal Cavity Surgery; 5.Severe spinal deform; 6.Atrial Fibrillation Catheter Ablation Surgical contraindication; 7.Significant abnormality on Swallowing Impairment Score; 8.Anticoagulant contraindications; 9.Drug allergy; 10.Patients with active infection; 11.Subject is pregnant or plans to become pregnant; 12.Mental impairment; 13.Subject with known alcohol or drug dependence; 14.Patients who have received other clinical research drugs or treatments within 3 months; 15.The researchers considered that the subjects were not suitable for the clinical study because of other serious systemic diseases or other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the distance from the trailing esophageal edge to the closest point of the ablation line; | — |
Countries
China
Contacts
Public ContactChangsheng Ma
Outcome results
None listed